Panelists highlight that menin inhibitors represent a breakthrough in the treatment of KMT2A-rearranged AML by targeting the disease’s core epigenetic drivers, with early clinical trials like ...

Acute myeloid leukemia (AML) is cancer that affects the blood and bone marrow. Doctors may recommend blood transfusions as part of AML treatment. The specific transfusion type and associated risks ...